13F Holdings
中文EN

EUDA EUDA Health Holdings Ltd

Services-Health Services · Nasdaq · SEC CIK 1847846 · Fiscal year ends 12/31

Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY70.0%
TTM net income YoY81.9%
TTM EPS YoY84.4%
Revenue 3-yr CAGR21.9%
Net income 3-yr CAGR—

Margins

Gross margin43.9%
Operating margin-36.3%
Net margin-40.7%
FCF margin-36.7%
EBITDA margin-33.5%

Returns

ROE—
ROA-162.4%
ROIC (approx.)—
Asset turnover4.00x

Leverage & solvency

Liabilities / assets348.6%
Debt / equity—
Current ratio0.18x
Interest coverage-10.84x

Cash quality & payout

Operating cash flow / net income0.88x
Accruals ratio-20.3%
Payout ratio—
Capex / revenue1.1%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2023Q2*2023-06-302023Q12023-03-312022Q12022-10-312022Q4*2022-07-312022Q32022-04-302022Q32022-03-312022Q22022-01-312022Q12021-10-31
Income statement
Revenue$104,276$1.70M———$2.67M——
Cost of revenue$64,184$1.30M———$1.40M——
Gross profit$40,092$403,598———$1.27M——
R&D expense—————$2,946——
SG&A expense$806,365$1.98M———$824,896——
Operating income-$738,974-$1.98M-$298,331-$1.23M-$481,638$75,312-$225,636-$45,587
Pretax income-$4.78M-$2.41M———$230,817——
Income tax—$985———$5,823——
Net income-$6.10M-$2.41M$201,012-$1.02M-$472,989$222,585-$224,890-$45,587
EBITDA-$740,381-$1.97M———$82,262——
EPS (basic)—-0.12———0.02—-0.02
EPS (diluted)—-0.12———0.02—-0.02
Weighted avg. shares (diluted)—20.19M———9.25M—1.88M
Balance sheet
Cash & equivalents—$837,292$265,852$193,546$546,887—$587,430$0
Receivables—$1.59M——————
Current assets—$24.80M$87.27M$86.78M$86.94M—$86.98M—
PP&E, net—$27,892——————
Total assets—$25.48M$87.27M$86.78M$86.94M—$86.98M$490,164
Current liabilities—$31.33M—————$506,628
Total liabilities—$31.42M$5.02M$4.73M$3.88M—$3.44M$506,628
Shareholders' equity-$5.98M-$5.95M-$4.02M-$3.72M-$2.49M$821,030-$2.01M-$16,464
Shares outstanding—20.19M2.45M2.45M2.45M—2.45M2.16M
Cash flow statement
Operating cash flow-$1.71M-$469,908-$123,800-$353,341-$540,543-$252,196——
Investing cash flow———$0$0-$29,326——
Financing cash flow$1.19M$525,328$196,106$0$500,000$331,439——
Depreciation & amortization-$1,407$3,981———$6,950——

Free plan shows the latest 8 periods; Pro shows all 10 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.